C430003P19Rik Activators would be a term applied to molecules that specifically increase the activity of the protein encoded by the gene C430003P19Rik. The process of discovering and developing activators for a given protein typically involves a multifaceted approach, beginning with high-throughput screening (HTS). This process utilizes automated platforms to test a large library of chemical compounds for their ability to modulate protein function. In the case of C430003P19Rik, the HTS assays would be designed to detect an upregulation in the protein's activity. These assays often employ reporter systems that can include changes in fluorescence or luminescence to indicate protein activity. Such systems enable rapid quantification and identification of compounds that can enhance the activity of C430003P19Rik. Those molecules that show a significant and reproducible increase in activity are then selected for more thorough validation through secondary assays. These secondary assays are crucial as they confirm the activator's specific action on the protein, eliminating any false positives that may have arisen due to non-specific effects or artifacts of the initial screening process.
Once a compound has been validated as a genuine activator of C430003P19Rik, it then undergoes detailed mechanistic studies to understand the interaction with the target protein. Structural analysis techniques, such as X-ray crystallography or nuclear magnetic resonance spectroscopy (NMR), can provide high-resolution images of the protein in complex with the activator molecule, revealing how the activator binds to the protein and induces an increase in activity. This structural information is vital for understanding the precise molecular interactions that lead to activation. Additionally, biophysical assays like surface plasmon resonance (SPR) and isothermal titration calorimetry (ITC) are employed to measure the binding kinetics and affinity between the C430003P19Rik protein and its activators. These assays can reveal how quickly the activator binds to the protein and how strongly it is retained, which are both important parameters for understanding how the activator functions at a molecular level. What follows is an iterative process of structure-activity relationship (SAR) studies, where chemists synthesize derivatives of the activator molecules to fine-tune their properties.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, enzymes responsible for breaking down cAMP. By preventing cAMP degradation, IBMX can sustain the activation of cAMP-dependent pathways, potentially enhancing the activity of C430048L16Rik if it's modulated by such pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is an activator of protein kinase C (PKC). If C430048L16Rik activity is influenced by PKC-mediated signaling, PMA would enhance C430048L16Rik by activating PKC, which could phosphorylate substrates that regulate C430048L16Rik activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Calcium signaling is crucial for numerous cellular processes, and if C430048L16Rik is affected by calcium-dependent mechanisms, ionomycin could enhance its activity by modulating these pathways. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is an inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to increased cytosolic calcium levels. Enhanced calcium signaling could indirectly activate C430048L16Rik if it is regulated by calcium-dependent pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore similar to ionomycin and can elevate intracellular calcium concentrations. This increase in calcium can enhance C430048L16Rik activity through the activation of calcium-sensitive signaling cascades. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol found in green tea with kinase inhibitory activity. If C430048L16Rik is negatively regulated by specific kinases, EGCG could indirectly enhance C430048L16Rik activity by inhibiting those kinases. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor. By inhibiting these kinases, Genistein can shift signaling pathways to reduce competition and enhance the activity of C430048L16Rik if it is regulated in part by tyrosine kinase activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is an inhibitor of phosphoinositide 3-kinases (PI3K). Inhibition of PI3K can lead to altered signaling downstream, potentially enhancing C430048L16Rik activity if it is modulated by PI3K/AKT pathways. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. By inhibiting p38, the compound could redirect cellular signaling to favor the activation of C430048L16Rik if p38 negatively influences C430048L16Rik activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a signaling sphingolipid that activates sphingosine-1-phosphate receptors, leading to various downstream signaling events. If C430048L16Rik is part of these signaling cascades, S1P could enhance its activity by activating these pathways. | ||||||